165 related articles for article (PubMed ID: 25912906)
1. Pathological role of adipose tissue dysfunction in cardio-metabolic disorders.
Shimizu I; Yoshida Y; Minamino T
Int Heart J; 2015 May; 56(3):255-9. PubMed ID: 25912906
[TBL] [Abstract][Full Text] [Related]
2. Endocrine functions of adipose tissue.
Waki H; Tontonoz P
Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue dysfunction contributes to obesity related metabolic diseases.
Blüher M
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):163-77. PubMed ID: 23731879
[TBL] [Abstract][Full Text] [Related]
4. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
5. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
6. Adipose tissue inflammation and metabolic dysfunction: a clinical perspective.
Tam CS; Redman LM
Horm Mol Biol Clin Investig; 2013 Sep; 15(1):19-24. PubMed ID: 25436729
[TBL] [Abstract][Full Text] [Related]
7. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
9. The complement system in human cardiometabolic disease.
Hertle E; Stehouwer CD; van Greevenbroek MM
Mol Immunol; 2014 Oct; 61(2):135-48. PubMed ID: 25017306
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of obesity and the risk for cardiovascular disease.
Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR
Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555
[TBL] [Abstract][Full Text] [Related]
11. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
De Boer MP; Meijer RI; Wijnstok NJ; Jonk AM; Houben AJ; Stehouwer CD; Smulders YM; Eringa EC; Serné EH
Microcirculation; 2012 Jan; 19(1):5-18. PubMed ID: 21883642
[TBL] [Abstract][Full Text] [Related]
12. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.
Gonçalves P; Araújo JR; Martel F
Eur Neuropsychopharmacol; 2015 Jan; 25(1):1-16. PubMed ID: 25523882
[TBL] [Abstract][Full Text] [Related]
14. Preface to special issue on: Adiposopathy in cancer and (cardio)metabolic diseases: an endocrine approach - Part 3.
Chetrite GS; Fève B
Horm Mol Biol Clin Investig; 2015 Apr; 22(1):3-5. PubMed ID: 26011938
[No Abstract] [Full Text] [Related]
15. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
16. Linking resistin, inflammation, and cardiometabolic diseases.
Park HK; Kwak MK; Kim HJ; Ahima RS
Korean J Intern Med; 2017 Mar; 32(2):239-247. PubMed ID: 28192887
[TBL] [Abstract][Full Text] [Related]
17. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
Mavri A; Alessi MC; Juhan-Vague I
J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
[TBL] [Abstract][Full Text] [Related]
18. Resistin- and Obesity-associated metabolic diseases.
Lazar MA
Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
[TBL] [Abstract][Full Text] [Related]
19. Obesity and cancer: the role of dysfunctional adipose tissue.
van Kruijsdijk RC; van der Wall E; Visseren FL
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2569-78. PubMed ID: 19755644
[TBL] [Abstract][Full Text] [Related]
20. New evaluations of redox regulating system in adipose tissue of obesity.
Park J; Chung JJ; Kim JB
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S11-6. PubMed ID: 17452057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
